MedPath

PN-232

Generic Name
PN-232

A Study of JNJ-75105186 in Healthy Japanese and Chinese Participants

Phase 1
Withdrawn
Conditions
Healthy
Interventions
Other: Placebo
First Posted Date
2021-12-15
Last Posted Date
2025-02-03
Lead Sponsor
Janssen Pharmaceutical K.K.
Registration Number
NCT05159128
Locations
🇯🇵

Souseikai Fukuoka Mirai Hospital, Fukuoka-shi, Japan

Pharmacokinetics of PN-232 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Subjects
Interventions
Drug: Placebo
First Posted Date
2021-03-29
Last Posted Date
2022-10-03
Lead Sponsor
Protagonist Therapeutics, Inc.
Target Recruit Count
48
Registration Number
NCT04819620
Locations
🇦🇺

Protagonist Study Site, Nedlands, Western Australia, Australia

🇦🇺

Protagonist Clinical Site, Adelaide, South Australia, Australia

© Copyright 2025. All Rights Reserved by MedPath